{"name":"Michael K. Gibson","slug":"michael-k-gibson","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Human Papillomavirus Tumor Antigen Vaccine","genericName":"Human Papillomavirus Tumor Antigen Vaccine","slug":"human-papillomavirus-tumor-antigen-vaccine","indication":"Prevention of cervical, vulvar, vaginal, penile, and anal cancers caused by Human Papillomavirus","status":"phase_2"}]}],"pipeline":[{"name":"Human Papillomavirus Tumor Antigen Vaccine","genericName":"Human Papillomavirus Tumor Antigen Vaccine","slug":"human-papillomavirus-tumor-antigen-vaccine","phase":"phase_2","mechanism":"Stimulates an immune response against Human Papillomavirus (HPV) tumor antigens","indications":["Prevention of cervical, vulvar, vaginal, penile, and anal cancers caused by Human Papillomavirus"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNQWdhS09yTDU0b3hoRUVTRkJXQVljTzlpNTV3NmJDR1FTbVVfbmhoeVJjV0JtSkY0elBQT0xJdjVfVGlJVUtlSHFsT3E4X3F3YWtDd0RxSnBVS0VFUUFjNl9yZWY2WnZBVVF4ZVN0ZmhpZWlBd2xaVkJHaG1LY0l0VjVHYVB6N0lWbEJnMkxXOG1Ob0lGQ0w1TUYxci1BY0ZpTWMwWGJQdmRiLXRqVEMxQlVfMXVXMXFRdWc?oc=5","date":"2026-01-07","type":"pipeline","source":"Investing.com","summary":"Recursion pharma director Gibson sells $170k in shares - Investing.com","headline":"Recursion pharma director Gibson sells $170k in shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE5QakJ2Um4zUU9oX0JEUnJqQTVqekoxNEU5NndxcEpOZ0d0dEpORjcxN1pRaGxXN0hCYTFUeDBleC1pY0FMemxZU1hLMTZJNFYxaVNHYjl3ZWZRTi1wZUFMYmhobw?oc=5","date":"2025-08-25","type":"trial","source":"Wiley Online Library","summary":"Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma - Wiley Online Library","headline":"Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNTU1DTjE4NDJSSHhpNGJ4cUh1TWE4TDFjWUtnZnIxaUF0d2ZxQUlTSkx6bzc0WGR2WHl1Q2p2cFVDdHRUdVJVSTdBRndQaVk3WmlTdE9jWmNEczhaeXM4UDM0VFRHZkxoZHExY0tnWkgyRDYtOTFDTGNSbHVtUm5Iclh0MnVibjdCSHRnc3B4cVhMTUQz0gGaAUFVX3lxTE8ybTZ3WkI1YkpqUDM3N1VfTWJaTlZVdlNIaDQtU25zd2RFTkVyWnBiVERSeW9iQTFkVDF6OHI0QTRSbl9KNGJQa1RRS0QtZHFaUHdUWnQtVlZCeXhBNVdOZW5KZ1Y4UFRjUHFtRmMtTVhlZXc4NUU3MlFId2t4SDdIdDJKckhyWF8xNTdZNGpCcHhoYWozRGJZd0E?oc=5","date":"2024-10-10","type":"pipeline","source":"Barbados Today","summary":"Pharmacy at Eunice Gibson Polyclinic closed on Friday - Barbados Today","headline":"Pharmacy at Eunice Gibson Polyclinic closed on Friday","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPVkI5OU8zR2JfcHoyaUx6dWhXWHBqakRMRjFwUm43NnZWci1ndVdCYWNxWnhTNFlFcFhVM1MzenoybG9mMGd0ZU9fM1VSdGRLYzJnQTZYSlJaVXRhbDFBdTRFbTZHWFp1NXNPYThieGhjZlI0WkRQNnlYMURjUzBjY2MwMnlUZnQtalBUSnNRTUZEc1dsd3BXOGJBb3pLeTV5RWQ1OUxWR2JTWHNfTlFUdi1kSjZtMWF1Rk9tbV9ZS0hERXhlSmR0Q3E5a2pxS3BYSWM2ZHNXa09rTS1BN1hJbzdodGNpd00?oc=5","date":"2024-03-25","type":"pipeline","source":"The ASCO Post","summary":"Esophageal Squamous Cell Cancer: Overall Survival Improved With Tiragolumab and Atezolizumab Plus Chemotherapy - The ASCO Post","headline":"Esophageal Squamous Cell Cancer: Overall Survival Improved With Tiragolumab and Atezolizumab Plus Chemotherapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOYUpVbGY2U1Z5MHVXMTc0TEJYR09qNDZSQ1J2Q2ZHaExUdXZFWERpaDRTMXBQT1BfWGFLSXpabUgxNTZ1S093dUZBX09fSnVRMndwRFdaUVpZMHlHbVFnZm9FaXJFaDNyZF9kSzVTNnNjVGdxZ0hRNGdGUVpWQVhNeXlSbEQyTlBEb24wV3hxUkoxc1Z6OW1ScGtCcXhsSk1SRDhUa05uWkEyWU5sejJHTW1uZnNpTG9BSGVzdGg5VlY3cnBPWlJhczBTdGNuTTc4RkpraQ?oc=5","date":"2022-09-15","type":"pipeline","source":"Healio","summary":"Pembrolizumab plus chemoradiotherapy shows favorable EFS trend in head/neck cancer - Healio","headline":"Pembrolizumab plus chemoradiotherapy shows favorable EFS trend in head/neck cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQcUNzTmwyMlh0dmZnZVpDU0RXbWJ3andMTzFES0R2dXd2WkVzQ2hvVmJoNlRPYTUtZHhHY1B1Mi1rWDlIVXZ0LVpTN1JsSEQzbWF6aHZtSk1iXzE4Y0lZQXZrYVBBcWRfTnIzNm12VWo1Z3c4UmdpR2JVMFRNWWh3T3hKY2htWlpuUXpWVTlmdUFDYjE0OGpLSzZUYW0zVng5YjlSMTFtMEJqVnBfMzNVZGUtdEh6cFdSTHdWS3RRNjJKQXc?oc=5","date":"2022-01-23","type":"pipeline","source":"Oncology News Central","summary":"FOLFOX Minus Oxaliplatin May Be Appropriate in Certain Colorectal Cancer Patients - Oncology News Central","headline":"FOLFOX Minus Oxaliplatin May Be Appropriate in Certain Colorectal Cancer Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQOG8xRm50MXNTVkQ3RFUwR0JvS3RrUmliZ2xCRFptUW1nWlhyaU40cWtKSzc3Z1h1UDktWjRqZ2s2R2YxQWZucm1fNDBqUktKNnVxMVZtN2Z2WDVUdkpQaTVGVDBOMmVOYmFPSEJYQWJsUEI5cW9CZmVPbThUd3BxN2R4RDF6TExQS2ZBUDFHSFpPWVBfdDJTbTVaNDBiU0hNN1p4X2VIVFA4RXBjc3o3azJBZGV4OFVN?oc=5","date":"2022-01-22","type":"pipeline","source":"Oncology News Central","summary":"TACE and Lenvatinib Improve Advanced Liver Cancer Survival - Oncology News Central","headline":"TACE and Lenvatinib Improve Advanced Liver Cancer Survival","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNM3NXRGlnWjA0eU4weFRSektnYmxpTTROeTVjVnBBdVF0ckhSNzJUUnV5TUdzZ3Jra1JSNkNYQU5Vc21pRFFKcU0tQlROQjRGLVlQNnRhWFZnRmVXX3hyVGlnYmVhY09XNndoRWxGMEY0WU02NE5iWGNLelRMZEsyMkdmZDRVRDZEYS1WbERPN0t4R2ZLLWtVRDEzWE1UU3dzSmdEWFFPVjF1S2Q1aVpleE9DYjJDdEtCd1JFOGJJUUJFQ0VmRjBN?oc=5","date":"2022-01-21","type":"pipeline","source":"Oncology News Central","summary":"Triplet Chemotherapy Regimen Improves Overall Survival in Advanced Esophageal Cancer - Oncology News Central","headline":"Triplet Chemotherapy Regimen Improves Overall Survival in Advanced Esophageal Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE5UV3RVbGVUUmlzMzdESnMtTEFaZTBVRzJJWGxXYjNTY1N6NTlsdjhEZjRGMnBQVVA1RmZCN2NQQmxYZjIyTzJiVXpsbG5RSjFNYkN4UlhpcVZTTGptRGpidw?oc=5","date":"2016-11-14","type":"trial","source":"NEJM","summary":"Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI - NEJM","headline":"Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}